AVCNF / Avicanna reports 24% revenue jump in 2022

TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical more_horizontal

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) has announced that Chandra Panchal, PhD is retiring as chairman of its board of directors and that it will in more_horizontal

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) saw its revenue increase by 200% year-over-year in the second quarter driven by its acquisition of the Medical Ca more_horizontal

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) said it has closed its previously-announced acquisition of the Medical Cannabis by Shopper's Business from Shopp more_horizontal

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) has unveiled the initial portfolio offering for the MyMedi.ca cannabis care platform ahead of its launch on Augus more_horizontal

The MyMedi.ca medical cannabis care platform is preparing to launch August 1, 2023 The new cannabis care platform will offer a diverse portfolio of pr more_horizontal

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) announced that it has completed, through its majority-owned Santa Marta Golden Hemp subsidiary, the commercial e more_horizontal

Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) reported that its revenue has increased by about 200% quarter-over-quarter following its acquisition of the Medic more_horizontal